ICU · Respiratory / ventilation
VA-ECMO for Cardiogenic Shock & Extracorporeal CPR (ECPR)
Also known as VA-ECMO · Veno-arterial ECMO · Extracorporeal life support · ECLS · Extracorporeal cardiopulmonary resuscitation · ECPR · Femoro-femoral ECMO · Harlequin syndrome · Differential hypoxaemia · LV distension · Bridge to recovery · SAVE score · SCAI shock stages · Distal perfusion cannula
Veno-arterial ECMO (VA-ECMO) drains venous blood, oxygenates and decarboxylates it, and returns it to the arterial system — providing both circulatory and respiratory support for refractory cardiogenic shock (a bridge to recovery, decision, transplant, or durable LVAD) and for refractory cardiac arrest (extracorporeal CPR, ECPR). Cannulation is peripheral (femoro-femoral, rapid, for shock and ECPR) or central. The complications include bleeding (the largest), limb ischaemia (mitigated by a distal perfusion cannula), left-ventricular distension and pulmonary oedema (the failing LV cannot eject against the retrograde aortic flow — may need an Impella or vent), differential hypoxaemia (the Harlequin or north-south syndrome), thrombosis, haemolysis, and infection. ECPR outcomes are best in selected, rapidly-cannulatable patients. Severity and reversibility are graded by the SCAI A-E stages and the SAVE score; weaning is by staged flow reduction with echocardiographic and pulse-pressure recovery assessment.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Meet the patient
It is 02:10. A 61-year-old with an anterior STEMI had primary PCI two hours ago. The LAD was stented, but he remains in SCAI stage D shock — deteriorating shock despite escalating therapy, with rising lactate and multi-pressor dependence. The cardiology consultant is cannulating the right femoral vein and artery at the bedside; the perfusionist is priming the circuit; the cardiac surgeon is on the phone about a backup LV vent. The junior asks: "Isn't this just a big heart-lung machine?"[1][4]
Two facts decide the next hour. VA-ECMO is not a treatment — it is a bridge: it buys time for the heart (or the lungs) to recover, or for a decision (transplant, durable LVAD, withdrawal). And the biggest complication is bleeding, not thrombosis, because systemic anticoagulation meets two large-bore cannulae. Hold those two facts and the rest of this topic slots into place.[1]
References15ShowHide
- [1]Choubey U, Mehta K, et al. Extracorporeal membrane oxygenation in cardiogenic shock: evidence, limitations, and patient selection in the contemporary era Postgrad Med, 2026.PMID 42178728
- [2]Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial Lancet, 2020.PMID 33197396
- [3]Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score Eur Heart J, 2015.PMID 26033984
- [4]Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019 Catheter Cardiovasc Interv, 2019.PMID 31104355
- [5]Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock N Engl J Med, 2012.PMID 22920912
- [6]Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients Ann Thorac Surg, 2014.PMID 24210621
- [7]Marbach JA, Faugno AJ, Pacifici S, et al. Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: A systematic review and Meta-analysis Int J Cardiol, 2022.PMID 35523371
- [8]Martucci G, Grasselli G, Tanaka K, et al. Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study Am J Respir Crit Care Med, 2024.PMID 37943110
- [9]Kiskaddon AL, Do NL, Williams P, et al. Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature Semin Thromb Hemost, 2023.PMID 37643746
- [10]Balthazar T, et al. Prevention and Management of Hemolysis when Utilizing Mechanical Circulatory Support Interv Cardiol Clin, 2026.PMID 42209077
- [11]Kinoshita G, Ito-Masui A, Kato T, et al. Veno-venous extracorporeal membrane oxygenation in managing acute respiratory distress syndrome associated with hemolytic uremic syndrome and septic shock: a case report J Artif Organs, 2025.PMID 38916825
- [12]Torre DE, Pirri C Harlequin Syndrome in Venoarterial ECMO and ECPELLA: When ECMO and Native or Impella Circulations Collide - A Comprehensive Review Rev Cardiovasc Med, 2025.PMID 40927093
- [13]Pöss J, Jentzer J, Desch S, et al. Prognostic impact of SCAI shock severity classes in AMI-related cardiogenic shock: A sub-study of the ECLS-SHOCK Trial ESC Heart Fail, 2025.PMID 41083288
- [14]Belohlavek J, et al. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial JAMA, 2022.PMID 35191923
- [15]Suverein MM, et al. Early Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest N Engl J Med, 2023.PMID 36720132